Needham analyst Matt McGinley has a To sell Review of Aurora Cannabis (ACB) today. The company’s shares closed at $ 7.32 last Thursday.
According to TipRanks.com, McGinley is a 5-star analyst with an average return of 73.6% and a success rate of 65.5%. McGinley covers the materials sector and focuses on stocks like Green Thumb Industries, Curaleaf Holdings, and Trulieve Cannabis.
Aurora Cannabis has analyst consensus from Moderate Sell with a target price consensus of $ 8.11, an uptrend of 3.6% from current levels. In a report released on May 11th, CIBC also downgraded the stock to sell with a target price of $ 9.00.
Check out Today’s Analyst’s Recommended Stocks >>
Based on Aurora Cannabis’ most recent earnings release for the quarter ended December 31, the company reported quarterly revenue of $ 67.67 million and a GAAP net loss of $ 293 million. By comparison, the company had revenue of $ 55.14 million and a GAAP net loss of $ 1.29 billion last year.
TipRanks has tracked 36,000 company insiders and found that some of them are better than others when it comes to the timing of their transactions. See which 3 stocks are most likely to move after their inside activity.
Aurora Cannabis, Inc. is engaged in the manufacture, distribution and sale of cannabis products. The company also manufactures and sells indoor growing systems and hemp products. The company was founded on December 21, 2006 by Terry Booth and Steve Dobler and is headquartered in Edmonton, Canada.